Issuer news 17259
02/29/2024 13:55 – Other information
02/29/2024 13:53 – Financial report
02/29/2024 13:52 – Financial report
02/29/2024 13:52 – Financial report
02/29/2024 13:52 – Financial report
02/29/2024 13:36 – Financial report
02/29/2024 13:35 – Financial report
02/29/2024 12:53 – Financial report
02/29/2024 12:53 – Financial report
02/29/2024 11:27 – Financial report
02/29/2024 11:27 – Financial report
02/29/2024 11:27 – Financial report
02/29/2024 11:26 – Financial report
02/29/2024 11:21 – Other information
02/29/2024 10:39 – Inside information
Double-digit growth in 2023 resulted in twice the amount of business compared to 2018 and confirmed the status of the largest domestically owned pharmaceutical company.